Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/20/2025

Meniere's Disease Management with Betahistine and Prochlorperazine

Introduction to Medications

  • The American Academy of Otolaryngology-Head and Neck Surgery recommends betahistine as an option for maintenance therapy to reduce symptoms or prevent Meniere's disease attacks, though the evidence remains equivocal 1
  • Betahistine is specifically indicated for maintenance therapy, with a recommended starting dose of 48 mg daily, and should be continued for at least 3 months to evaluate efficacy 4

Role of Betahistine

  • The mechanism of betahistine involves histamine H1 receptor weak agonism and H3 receptor antagonism, potentially increasing vasodilation to the inner ear and affecting central vestibular compensation 1
  • The American Academy of Otolaryngology-Head and Neck Surgery offers betahistine as an option based on observational studies, with the caveat that the most recent high-quality BEMED trial showed no significant difference between betahistine and placebo 3

Role of Prochlorperazine

  • Prochlorperazine is an antivertigo medication used for acute vertigo symptoms, not for maintenance therapy, and functions as an antiemetic and vestibular suppressant during acute attacks but does not prevent future episodes 2
  • Prochlorperazine can cause extrapyramidal side effects with prolonged use and is not appropriate for chronic maintenance therapy 2

Evidence Quality Assessment

  • A 2016 Cochrane review suggested a 56% reduction in vertigo with betahistine versus placebo, but the more recent and higher-quality BEMED trial found no significant difference between betahistine and placebo 3
  • The American Academy of Otolaryngology-Head and Neck Surgery still offers betahistine as an option based on the balance of benefits and harms, recognizing variable patient responses 1

Safety Profiles

  • Absolute contraindication for betahistine is pheochromocytoma, and it should be used with caution in asthma and peptic ulcer disease 4
  • Common side effects of betahistine include headache, balance disorder, nausea, nasopharyngitis, feeling hot, eye irritation, palpitations, and upper GI symptoms 3

Clinical Algorithm

  • For active Meniere's disease with recurrent vertigo attacks, use prochlorperazine for immediate symptom relief during acute vertigo episodes, and consider betahistine for maintenance therapy 2, 1, 4

REFERENCES

1

clinical practice guideline: ménière's disease. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

2

Betahistine Dosing for Meniere's Disease [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Betahistine in Meniere's Disease Treatment [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

clinical practice guideline: ménière's disease. [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020